Hereditary cancer genetic testing can help inform medical management options for your patients with colorectal cancer.1
Genetic testing is underutilized in patients with colorectal cancer—despite insurance coverage1
There are more than one million colorectal cancer survivors in the United States, and the majority haven’t undergone hereditary cancer genetic testing.2,3
1 in 9 patients with colorectal cancer may have clinically actionable variants4
Identifying a clinically actionable variant may impact your medical management by informing risk assessment and personalized treatment options.1,5
We partner with you to integrate genetic testing into your clinic workflow to help increase patient access
- When patients are referred out to another provider for testing, less than half of those eligible for hereditary cancer genetic testing follow through on submitting test samples.10
- In a study of young adults (ages 18–49) with colorectal cancer, referral to and attendance at genetic counseling appointments differed by race/ethnicity. Black patients were significantly less likely to be referred to a genetic counselor and less likely to attend appointments compared to Hispanic and White patients.11